IIM
IMNM icon

INTECH Investment Management’s Immunome IMNM Stock Holding History

INTECH Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$679K Buy
31,038
+4,023
+15% +$89.5K 0.01% 1189
2025
Q4 		$580K Buy
27,015
+4,311
+19% +$75.7K 0.01% 1429
2025
Q3 		$266K Sell
22,704
-17,861
-44% -$178K ﹤0.01% 1901
2025
Q2 		$377K Buy
40,565
+6,141
+18% +$50.3K ﹤0.01% 1761
2025
Q1 		$232K Buy
34,424
+15,463
+82% +$148K ﹤0.01% 2014
2024
Q4 		$201K Buy
18,961
+3,974
+27% +$48K ﹤0.01% 2028
2024
Q3 		$219K Buy
+14,987
New +$213K ﹤0.01% 1680

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

INTECH Investment Management's IMNM Position: Q1 2026 in Review

INTECH Investment Management increased its Immunome (IMNM) stake by 15% in Q1 2026, buying an estimated $89.5K and bringing the position to 31,038 shares worth $679K. The position accounts for 0.01% of the portfolio, ranked #1189.

INTECH Investment Management first reported a position in IMNM in Q3 2024 and has held it in 7 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • INTECH Investment Management held 31,038 shares of Immunome worth $679K as of Q1 2026.
  • INTECH Investment Management bought 4,023 Immunome shares in Q1 2026, an estimated $89.5K.
  • Immunome made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1189 holding.
  • INTECH Investment Management first reported a position in Immunome in Q3 2024 and has held it in 7 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.